Home > Boards > US OTC > Medical - Drugs > Alseres Pharmaceuticals, Inc. (ALSE)

ALSE vol. chart seems someone preload 700k back

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
funnyG986 Member Profile
 
Followed By 546
Posts 32,092
Boards Moderated 2
Alias Born 09/23/10
160x600 placeholder
funnyG986   Friday, 09/05/14 01:24:24 PM
Re: Natural Trader post# 12
Post # of 26 
ALSE vol. chart seems someone preload 700k back in June. Phase III clinic trial.

Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). Our lead product candidate is Altropane®, a proprietary molecular imaging agent used to diagnose Parkinson's disease and dementia. Altropane is presently in Phase III clinical development for the diagnosis of Parkinson's disease. Our development strategy for Altropane anticipates entering into one or more partnerships to ensure development and commercialization of the product.

http://www.alseres.com/



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences